GvHD Prophylaxis

Madan Jagasia | EBMT 2019 | Six month follow-up results from the phase II REACH1 trial

L:

45th Annual Meeting of the EBMT, 24–27 March 2019, Frankfurt, DE

Madan Jagasia

Vanderbilt University Medical Center, Nashville, US

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!